Resultados de la búsqueda 1571-1580 de 5211 para Stretch+marks

  1. Oncología (médica) - Ensayos clínicos

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to estimate the circulating tumor DNA (ctDNA)detection rate and mutational load in breast cancer patients with indications for ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to identify the side effects and best dose of abemaciclib when given together with olaparib in treating patients with ovarian ...

  4. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper ...

  7. Oncología (médica) - Ensayos clínicos

    The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of the Mayo Clinic system so ...

  8. Oncología (médica) - Ensayos clínicos

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...

  9. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Scottsdale/Phoenix, Ariz. The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study ia to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...